Online citations, reference lists, and bibliographies.
← Back to Search

Major Depression Following Smoking Cessation.

L. Covey, A. Glassman, F. Stetner
Published 1997 · Psychology, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
OBJECTIVE The authors examined the incidence and predictors of major depression following successful smoking cessation treatment, with special attention to the influence of past major depression. METHOD Three-month follow-up data were obtained from 126 subjects who successfully completed a 10-week smoking cessation program. RESULTS The 3-month incidence of new major depression following treatment for nicotine dependence was 2%, 17%, and 30% among subjects with histories of no major depression, single major depression, and recurrent major depression, respectively. A history of major depression and persistent withdrawal symptoms independently predicted posttreatment major depression. CONCLUSIONS Continued patient care beyond the 2-4-week period associated with the nicotine withdrawal syndrome is indicated when abstinence is attempted by smokers with prior major depression.
This paper references



This paper is referenced by
10.1080/10550887.2020.1826104
The prevalence of depression symptoms after smoking cessation: a systematic review and meta-analysis
S. Amiri (2020)
10.1093/ntr/ntaa036
Longitudinal association between smoking abstinence and depression severity in those with baseline current, past, and no history of major depressive episode in an international online tobacco cessation study.
N. H. Liu (2020)
10.1016/j.jad.2019.11.145
Prenatal tobacco smoking is associated with postpartum depression in Japanese pregnant women: The japan environment and children's study.
Meishan Cui (2019)
10.1016/j.ejphar.2019.172732
Off-label uses of drugs for depression.
Sigrid S. Skånland (2019)
10.1038/s41398-018-0258-8
Genome-wide association study identifies glutamate ionotropic receptor GRIA4 as a risk gene for comorbid nicotine dependence and major depression
Hang Zhou (2018)
10.1038/s41380-018-0219-x
Cholinergic Regulation of Mood: From Basic and Clinical Studies to Emerging Therapeutics
S. Dulawa (2018)
10.1016/j.neubiorev.2017.08.018
Nicotine and networks: Potential for enhancement of mood and cognition in late-life depression
Jason A. Gandelman (2018)
10.1016/j.rmr.2018.04.004
[The influence of anxiety and depression on COPD exacerbations].
M. Underner (2018)
Depressed Mood Improvement through Nicotine Dosing ( Depressed MIND Study ) Version 1 . 3 , 04 / 13 / 2017 VICTR : VR 20324 Clinicaltrials . gov Identifier : NCT 02816138 PI :
W. Taylor (2018)
10.2174/1570159X15666170915142122
Why are Antidepressant Drugs Effective Smoking Cessation Aids?
M. Shoaib (2018)
10.1016/j.neuropharm.2018.01.017
Ketamine for the treatment of addiction: Evidence and potential mechanisms
I. Ezquerra-Romano (2018)
10.1007/s12160-016-9834-4
Predictors of Smoking Cessation and Relapse in Cancer Patients and Effect on Psychological Variables: an 18-Month Observational Study
A. Guimond (2017)
Nicotinic Receptor Intervention in Parkinson's Disease: Future Directions.
Y. Tizabi (2017)
10.1016/J.LPM.2016.03.011
Tabagisme et comorbidités psychiatriques
A. Dervaux (2016)
10.2147/NDT.S79354
Strategies to improve anxiety and depression in patients with COPD: a mental health perspective
A. Tselebis (2016)
10.1111/add.13290
Depression motivates quit attempts but predicts relapse: differential findings for gender from the International Tobacco Control Study.
J. Cooper (2016)
10.1016/j.euroneuro.2016.07.004
Alpha7 nicotinic acetylcholine receptor agonists and PAMs as adjunctive treatment in schizophrenia. An experimental study
M. Marcus (2016)
10.3390/ijerph13030288
E-Cigarettes for Immediate Smoking Substitution in Women Diagnosed with Cervical Dysplasia and Associated Disorders
Shirley A. James (2016)
10.1002/9781118753378.CH113
Pharmacological Treatment of Substance Abuse Disorders
W. Raby (2015)
10.1007/s12640-015-9577-1
Duality of Antidepressants and Neuroprotectants
Y. Tizabi (2015)
Pharmacological Evaluation of Choline on α4β2 Neuronal Nicotinic Acetylcholine Receptors
Ladislas Bizimana (2015)
10.1201/B18768-14
The Mediating Sex-Specific Effect of Psychological Distress on the Relationship Between Adverse Childhood Experiences
T. Strine (2015)
10.1016/bs.irn.2015.08.004
Nicotine Addiction and Psychiatric Disorders.
M. G. Kutlu (2015)
10.1016/j.neubiorev.2015.06.004
Negative affective states and cognitive impairments in nicotine dependence
F. S. Hall (2015)
10.1017/S0033291713003206
Smoking cessation is associated with lower rates of mood/anxiety and alcohol use disorders
P. Cavazos-Rehg (2014)
10.3122/jabfm.2014.03.130252
Tobacco Use Treatment in Primary Care Patients with Psychiatric Illness
Joseph M. Cerimele (2014)
10.1097/01.EPX.0000444060.91661.6f
Associations of depression and neuroticism with smoking behavior and motives among men in rural Qalyubia (Egypt).
G. Radwan (2014)
10.1186/1471-244X-14-10
Excess risk of chronic physical conditions associated with depression and anxiety
R. Bhattacharya (2014)
10.1016/J.ENCEP.2013.03.006
Prévalence du diabète de type 2 et facteurs associés au cours de la dépression
M. Sebbani (2014)
Nota de la directora
C. Gala (2014)
10.1007/S10902-015-9645-5
The Causal Relationship Between Happiness and Smoking: A Bootstrap Panel Causality Test
T. Chang (2014)
10.1155/2014/350262
Indicators of Psychiatric Disorders in Different Oncology Specialties: A Prevalence Study
Manuela Polidoro Lima (2014)
See more
Semantic Scholar Logo Some data provided by SemanticScholar